drugset / Trial / NCT06027554

The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults

NCT06027554

RandomizedCrossoverTriple-blindTreatment

Summary

The goal of this clinical trial is to test the effects of MitoQ supplementation in older adults and frail older adults with physical dysfunction and/or cognitive dysfunction. The main question\[s\] it aims to answer are: * To compare vascular function, oxidative stress levels, and physical and cognitive function among older adults and frail older adults with physical and cognitive dysfunction * To determine whether MitoQ supplementation has the potential to improve vascular function in central and cerebral vessels * To determine whether MitoQ supplementation can enhance physical and cognitive capabilities.

Timeline

Start
2024-10-07
Primary completion
2027-03-01
Completion
2028-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject MitoQ Small molecule 20 mg